The Evolving Landscape of Female-Specific Cardiovascular Care

The Evolving Landscape of Female-Specific Cardiovascular Care

Join NJ-ACC on February 12^th to hear our distinguished faculty of national experts discuss the latest 2026 guidelines, biological risk factors, and the complexities of menopausal transition beginning at 7:00 p.m.

Click Here to Register.

Lecture 1 | Biological Blueprints: Sex-Specific Risk Factors

Speaker: Rekha Mankad, MD, FACC (15 mins)

• Identify unique sex-specific risk enhancers: preeclampsia, gestational diabetes, premature menopause, and PCOS.
• Differentiate the disproportionately higher relative risk of traditional factors (smoking, DM, HTN) in women.
• Explain the influence of Sex as a Biological Variable (SABV) on vascular aging from menarche through menopause.

Lecture 2 | 2026 CV Prevention Update: Translating Guidelines

Speaker: Gina Lundberg, MD, FACC (15 mins)

• Implement updated 2026 risk-stratification algorithms for primary prevention.
• Apply tailored lipid-lowering and hypertension thresholds for women at various life stages.
• Develop strategies to improve GDMT adherence, addressing microvascular disease and statin-associated symptoms.

Lecture 3 | Navigating Menopause and Cardiovascular Risk

Speaker: Martha Gulati, MD, MS, FACC (15 mins)

• Assess CV risk prior to Menopausal Hormone Therapy (MHT) using traditional calculators and imaging/biomarkers.
• Differentiate contraindications to systemic hormone therapy in high-risk CVD patients.
• Develop shared decision-making strategies and non-hormonal alternatives for symptomatic women.

Expert Panel & Clinical Roundtable (15 mins)

Moderator: Sheila Sahni, MD (Chair, NJ-ACC Women in Cardiology)

Join our panelists and speakers for an interactive discussion on translating these lectures into daily clinical practice: Renee Bullock-Palmer, MD; Amy Ahnert, MD; Aviva Cohn, MD

*This program is pending accreditation approval for 1.5 hours of ACCME, ANCC, and AAPA credit.